1-9 of 9
Li Jia, PhD
Close
Sort by
Journal Articles

Phase 1 Study of Bisthianostat, an Orally Efficacious Pan-HDAC Inhibitor: Part Results of Safety, Pharmacokinetics and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma

Hong-Hui Huang, PhD MD, Jian Hou, PhD MD, Yang-Ming Zhang, PhD, Yu-Bo Zhou, PhD, Li Jia, PhD, Fa-Jun Nan, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5591.
https://doi.org/10.1182/blood-2019-129683
Published: 2019
Journal Articles

Developing the Next Generation of iPSC Cell-Based Immunotherapies

Raul Vizcardo, PhD, Nicholas Donald Klemen, MD, Rafiqul Islam, PhD, Devikala Gurusamy, PhD, Naritaka Tamaoki, MD, PhD, Li Jia, PhD, Zhiya Yu, PhD, Amanda N Hennings, PhD, Takuya Maeda, MD, Marta Bosch-Marce, PhD, Meghan L Good, MD, Svetlana Pack, PhD, David F. Stroncek, Francis A Flomerfelt, PhD, Michael J Kruhlak, PhD, Nicholas Phillip Restifo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3707.
https://doi.org/10.1182/blood-2018-99-118593
Published: 2018
Journal Articles

Overexpression of HMGB1 Receptor RAGE Is Associated with Worse Clinical Outcome in Patients with Chronic Lymphocytic Leukemia

Faith Norster, MBiochem, Andrew James Clear, BSc, Janet Matthews, Elena Hoxha, MSc, John Gribben, MDDSc, Li Jia, PhD MD
Journal: Blood
Blood (2015) 126 (23): 617.
https://doi.org/10.1182/blood.V126.23.617.617
Published: 2015
Journal Articles

Overexpression of BCL-2 Does Not Inhibit Autophagy in Human Follicular and Diffuse Large B-Cell Lymphomas

Aine McCarthy, PhD, Andrew James Clear, BSc, Jacek Marzec, Rita Coutinho, MD, Robert D. Petty, PhD, Janet Matthews, Andrew Wilson, Sameena Iqbal, Maria Calaminici, MD PhD, John G. Gribben, MD DSc, Li Jia, PhD MD
Journal: Blood
Blood (2014) 124 (21): 3007.
https://doi.org/10.1182/blood.V124.21.3007.3007
Published: 2014
Journal Articles

Tocilizumab Overcomes Chemo-Resistance Of CLL Cells

Fengting Liu, MD Ph.D, Li Jia, PhD, MD, Ping Wang, MD, Tim Farren, PhD, Samir G Agrawal, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5305.
https://doi.org/10.1182/blood.V122.21.5305.5305
Published: 2013
Journal Articles

HMGB1 Activates TLR9/RAGE Signalling Pathway and Sustains Chronic Lymphocytic Leukemic Cell in Vitro Survival

Amani Al-Malti, John G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath, Li Jia, PhD, MD
Journal: Blood
Blood (2012) 120 (21): 3860.
https://doi.org/10.1182/blood.V120.21.3860.3860
Published: 2012
Journal Articles

Inhibition of Autophagy by Chloroquine Sensitises Lymphoma Cells to ABT-737-Induced Apoptosis

Aine McCarthy, Vincent Yeung, John G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath, Li Jia, PhD, MD
Journal: Blood
Blood (2012) 120 (21): 1625.
https://doi.org/10.1182/blood.V120.21.1625.1625
Published: 2012
Journal Articles

Activation of Mitochondrial STAT3 Increases Mitochondrial Respiration and Inhibits Oxidative Stress in Chronic Lymphocytic Leukemic Cells

Li Jia, PhD, MD, Nadiha Uddin, John G. Gribben, MD, DSc
Journal: Blood
Blood (2011) 118 (21): 287.
https://doi.org/10.1182/blood.V118.21.287.287
Published: 2011
Journal Articles

Potentiation of Bortezomib-Induced Killing of Lymphoma Cells by Inhibition of Autophagy and Prevention of I-κBα Degradation

Li Jia, PhD, MD, Ganga Gopinathan, Johanna T Sukumar, John G. Gribben, MD, DSc
Journal: Blood
Blood (2010) 116 (21): 116.
https://doi.org/10.1182/blood.V116.21.116.116
Published: 2010